| Stereotactic abative body radiotherapy (SABR) for oligometastatic prostate cancer: a prospective clinical trial S Siva, M Bressel, DG Murphy, M Shaw, S Chander, J Violet, KH Tai, ... European urology 74 (4), 455-462, 2018 | 611* | 2018 |
| Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer M Ng, T Leong, S Chander, J Chu, A Kneebone, S Carroll, K Wiltshire, ... International Journal of Radiation Oncology* Biology* Physics 83 (5), 1455-1462, 2012 | 204 | 2012 |
| High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a Phase II trial M Barkati, SG Williams, F Foroudi, KH Tai, S Chander, S van Dyk, A See, ... International Journal of Radiation Oncology* Biology* Physics 82 (5), 1889-1896, 2012 | 147 | 2012 |
| Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy TCS Woo, R Choo, M Jamieson, S Chander, R Vieth Nutrition and Cancer 51 (1), 32-36, 2005 | 139 | 2005 |
| Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer: a multi-institutional analysis comparing the outcome and toxicity of stereotactic body … E De Bleser, BA Jereczek-Fossa, D Pasquier, T Zilli, N Van As, S Siva, ... European urology 76 (6), 732-739, 2019 | 128 | 2019 |
| Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy S Gill, J Thomas, C Fox, T Kron, A Rolfo, M Leahy, S Chander, S Williams, ... Radiation oncology 6, 1-7, 2011 | 125 | 2011 |
| Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial S Siva, D Pham, T Kron, M Bressel, J Lam, TH Tan, B Chesson, M Shaw, ... BJU international 120 (5), 623-630, 2017 | 111 | 2017 |
| Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma R Choo, G Thomas, T Woo, D Lee, B Kong, N Iscoe, C Danjoux, L Klotz, ... International Journal of Radiation Oncology* Biology* Physics 61 (3), 736-740, 2005 | 110 | 2005 |
| Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancer R Khor, G Duchesne, KH Tai, F Foroudi, S Chander, S Van Dyk, M Garth, ... International Journal of Radiation Oncology* Biology* Physics 85 (3), 679-685, 2013 | 102 | 2013 |
| Twenty-five-year experience with radical chemoradiation for anal cancer JM Tomaszewski, E Link, T Leong, A Heriot, M Vazquez, S Chander, ... International Journal of Radiation Oncology* Biology* Physics 83 (2), 552-558, 2012 | 101 | 2012 |
| Stereotactic radiotherapy and short-course pembrolizumab for oligometastatic renal cell carcinoma—the RAPPORT trial S Siva, M Bressel, ST Wood, MG Shaw, S Loi, SK Sandhu, B Tran, ... European urology 81 (4), 364-372, 2022 | 90 | 2022 |
| Outcomes of unplanned sarcoma excision: impact of residual disease C Charoenlap, J Imanishi, T Tanaka, J Slavin, SY Ngan, S Chander, ... Cancer medicine 5 (6), 980-988, 2016 | 67 | 2016 |
| A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma J Lewin, KK Khamly, RJ Young, C Mitchell, RJ Hicks, GC Toner, ... British journal of cancer 111 (12), 2254-2261, 2014 | 50 | 2014 |
| Seminal vesicle intrafraction motion analysed with cinematic magnetic resonance imaging S Gill, K Dang, C Fox, M Bressel, T Kron, N Bergen, N Ferris, R Owen, ... Radiation oncology 9, 1-8, 2014 | 42 | 2014 |
| How are hemoglobin levels affected by androgen deprivation in non-metastatic prostate cancer patients? R Choo, S Chander, C Danjoux, G Morton, A Pearce, G Deboer, ... The Canadian journal of urology 12 (1), 2547-2552, 2005 | 35 | 2005 |
| Outcomes of preoperative radiotherapy and resection of retroperitoneal sarcoma S Alford, P Choong, S Chander, M Henderson, G Powell, S Ngan ANZ Journal of Surgery 83 (5), 336-341, 2013 | 30 | 2013 |
| Prophylactic gastrostomy tubes for patients receiving radical radiotherapy for head and neck cancers: a retrospective review JH Chang, T Gosling, J Larsen, S Powell, R Scanlon, S Chander Journal of Medical Imaging and Radiation Oncology 53 (5), 494-499, 2009 | 26 | 2009 |
| Impact of prostate-specific membrane antigen positron emission tomography/computed tomography in the management of oligometastatic renal cell carcinoma C Udovicich, J Callahan, M Bressel, WL Ong, M Perera, B Tran, A Azad, ... European Urology Open Science 44, 60-68, 2022 | 24 | 2022 |
| Safety, efficacy, and patterns of failure after single-fraction stereotactic body radiation therapy (SBRT) for oligometastases P Sogono, M Bressel, S David, M Shaw, S Chander, J Chu, N Plumridge, ... International Journal of Radiation Oncology* Biology* Physics 109 (3), 756-763, 2021 | 24 | 2021 |
| Effect of combined treatment with salvage radiotherapy plus androgen suppression on quality of life in patients with recurrent prostate cancer after radical prostatectomy A Pearce, R Choo, C Danjoux, G Morton, DA Loblaw, E Szumacher, ... International Journal of Radiation Oncology* Biology* Physics 65 (1), 78-83, 2006 | 24 | 2006 |
